Posted July 20, 2009 in Blog, Botox and Facial Fillers, Uncategorized
Allergan Inc said on Thursday that its popular Botox wrinkle-smoother “worked as a treatment for adults suffering from chronic migraines”, according to late-stage clinical data.
Allergan said, “data from its phase III clinical trials showed a significantly greater decrease in headache days among patients receiving Botox, compared with those receiving a placebo. The treatment was well tolerated in patients suffering from chronic migraine.”
Based on this top-line analysis of its studies, Allergan hopes to file a supplemental biologics license application with the U.S. Food and Drug Administration for the use of Botox in chronic migraine by mid-2009.
